PTGS2 and schizophrenia: Finally, the miR-137 validated target PKA signaling gene set (MAPK1, MAPK3, TCF4, and PTGS2) is of particular interest given that enrichment of schizophrenia-risk associated variants within these targets was replicated in an independent cohort.